Shell Asset Management Co. Grows Holdings in GE HealthCare Technologies Inc. $GEHC

Shell Asset Management Co. grew its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 123.7% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 22,507 shares of the company’s stock after buying an additional 12,448 shares during the period. Shell Asset Management Co.’s holdings in GE HealthCare Technologies were worth $1,667,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of GEHC. JPMorgan Chase & Co. grew its stake in GE HealthCare Technologies by 49.9% in the 1st quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company’s stock worth $414,894,000 after buying an additional 1,711,963 shares in the last quarter. Nuveen LLC bought a new stake in shares of GE HealthCare Technologies in the 1st quarter worth approximately $77,058,000. Eminence Capital LP lifted its holdings in shares of GE HealthCare Technologies by 38.7% in the 1st quarter. Eminence Capital LP now owns 1,819,129 shares of the company’s stock worth $146,822,000 after acquiring an additional 507,101 shares during the last quarter. Homestead Advisers Corp lifted its holdings in shares of GE HealthCare Technologies by 92.7% in the 1st quarter. Homestead Advisers Corp now owns 988,600 shares of the company’s stock worth $79,790,000 after acquiring an additional 475,500 shares during the last quarter. Finally, Canada Pension Plan Investment Board lifted its holdings in shares of GE HealthCare Technologies by 15.2% in the 1st quarter. Canada Pension Plan Investment Board now owns 3,111,398 shares of the company’s stock worth $251,121,000 after acquiring an additional 409,636 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Up 0.9%

NASDAQ:GEHC opened at $75.13 on Thursday. The company has a fifty day moving average of $74.22 and a 200 day moving average of $72.47. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $94.80. The company has a quick ratio of 0.93, a current ratio of 1.16 and a debt-to-equity ratio of 0.85. The firm has a market capitalization of $34.30 billion, a P/E ratio of 15.40, a P/E/G ratio of 2.85 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, July 30th. The company reported $1.06 EPS for the quarter, beating analysts’ consensus estimates of $0.91 by $0.15. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The company had revenue of $5 billion during the quarter, compared to analyst estimates of $4.96 billion. During the same period in the prior year, the business posted $1.00 EPS. The firm’s revenue was up 3.5% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. On average, research analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 24th will be issued a $0.035 dividend. The ex-dividend date is Friday, October 24th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is 2.87%.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on GEHC. Citigroup lowered shares of GE HealthCare Technologies from a “buy” rating to a “neutral” rating and lowered their price objective for the stock from $93.00 to $83.00 in a report on Tuesday. Weiss Ratings restated a “hold (c)” rating on shares of GE HealthCare Technologies in a report on Saturday, September 27th. Wall Street Zen lowered shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, September 20th. BTIG Research restated a “buy” rating on shares of GE HealthCare Technologies in a report on Monday, July 14th. Finally, Morgan Stanley set a $74.00 price target on shares of GE HealthCare Technologies in a report on Thursday, September 18th. Six equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, GE HealthCare Technologies currently has an average rating of “Moderate Buy” and a consensus target price of $85.78.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.